Bausch Health Companies Inc.
BHC.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.41% | 9.87% | 10.92% | 10.23% | 10.10% |
| Total Other Revenue | 19.79% | 13.83% | 9.68% | 7.61% | 2.13% |
| Total Revenue | 8.53% | 9.91% | 10.91% | 10.20% | 10.01% |
| Cost of Revenue | 8.64% | 8.71% | 10.14% | 8.92% | 9.27% |
| Gross Profit | 8.49% | 10.41% | 11.23% | 10.74% | 10.32% |
| SG&A Expenses | 12.87% | 13.07% | 15.42% | 12.78% | 9.77% |
| Depreciation & Amortization | -1.76% | 0.00% | -0.72% | -5.76% | -8.49% |
| Other Operating Expenses | 3,000.00% | 200.00% | 0.00% | 0.00% | 0.00% |
| Total Operating Expenses | 8.46% | 8.63% | 9.83% | 7.83% | 6.65% |
| Operating Income | 8.86% | 15.60% | 15.88% | 21.85% | 27.45% |
| Income Before Tax | 158.51% | 142.82% | 93.38% | -1,516.00% | -76.50% |
| Income Tax Expenses | 73.08% | 8.14% | -28.21% | -28.50% | -9.30% |
| Earnings from Continuing Operations | 83.09% | 88.22% | 77.72% | -168.25% | -34.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 70.83% | 36.84% | 254.55% | 1,100.00% | 1,300.00% |
| Net Income | 91.21% | 92.23% | 81.52% | -153.23% | -27.45% |
| EBIT | 8.86% | 15.60% | 15.88% | 21.85% | 27.45% |
| EBITDA | 4.62% | 8.84% | 8.39% | 9.04% | 9.93% |
| EPS Basic | 91.15% | 92.13% | 81.56% | -152.65% | -26.94% |
| Normalized Basic EPS | 63.96% | 70.25% | 65.19% | 313.61% | 468.15% |
| EPS Diluted | 91.16% | 92.14% | 81.58% | -151.03% | -26.81% |
| Normalized Diluted EPS | 63.95% | 70.24% | 65.17% | 314.11% | 468.06% |
| Average Basic Shares Outstanding | 1.82% | 1.87% | 0.09% | 0.08% | 0.05% |
| Average Diluted Shares Outstanding | 1.81% | 1.87% | 0.09% | 0.02% | 0.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |